Having worked in the Life Science sector for many years, I was curious to explore how large language models (LLM) like ChatGPT are steadily making its way into this traditionally slow-moving sector, especially given the multitude of compliance factors that need to be considered.
LLMs are proving to be highly effective at:
📌 Understanding and processing natural language.
📌 Identifying patterns and trends in large data sets.
📌 Synthesizing complex data into meaningful, actionable insights.
These capabilities make LLMs promising tools for addressing common challenges within Life Science such as:
💊 Processing vast amounts of data, scientific literature, and patents.
💊 Accelerating drug discovery and development processes.
💊 Streamlining the design of clinical trials, creating control groups, and interpreting complex data.
It's exciting to see that major companies like AstraZeneca, Pfizer, and Sanofi are already tapping into these tools.
💊 AstraZeneca use ChatGPT to analyze scientific literature and identify new drug targets for development.
💊 Pfizer leverage ChatGPT to automate the literature review process in drug discovery and development. This not only streamlined the process but also cut down costs.
💊 Sanofi, on the other hand, is actively collaborating with AI-focused biotech firms to integrate these language models into their drug discovery process, with the goal of accelerating knowledge sharing and progress.
However, implementing these tools in such a highly regulated business sector does come many challenges, many of which are relevant for several sectors .
📌 Lack of transparency in how the LLMs operate can be a significant barrier.
📌 Training data, the question arises whether current models are trained on the right or enough data? Gigantic life science companies own an abundance of internal data that is crucial for development but is not yet included in the open models.
📌 Privacy and security, ensuring that data is not leaked, is a top concern.
How do we solve these? For transparency, initiatives such as 'explainable AI' aim to make the decision-making process of AI models more understandable. With regards to training data, collaborations between Life Science companies and AI researchers could lead to more nuanced models trained on a wider range of data. Lastly, for privacy and security, leveraging technologies like differential privacy could offer a path forward. Still some work to be done here…
🥳 We are likely to witness a surge in collaborations between AI-focused companies and traditional life science organizations. This could ultimately lead to the faster development of safer drugs, which is a win for us all!
❓ Are you working within Life Science and using large language models?
❓If you're not using it for core business functions, what do you use it for?
❓Or is it still on the strategic level?
No comments:
Post a Comment